AN OPEN letter to Federal
Health Minister Sussan Ley has
been published by 27 medical
associations and health advocacy
groups, urging the immediate
inclusion of breakthrough hepatitis
C medications on the PBS.
Hepatitis Australia ceo Helen
Tyrrell said it was time for Ley
to intervene in the face of
“protracted” negotiations with
pharmaceutical companies.
She described the availability
of the new drugs as “too good to
miss,” providing the opportunity
to transform hepatitis C into a rare
condition.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Oct 15
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.